VIATRIS HEALTHCARE (PTY) LTD, — Tenofovir Importer Profile
Pharmaceutical Importer · #9 buyer for Tenofovir · $2.7M import value · 54 shipments · SOUTH AFRICA · DGFT Verified
VIATRIS HEALTHCARE (PTY) LTD, is the #9 importer of Tenofovir from India with $2.7M in import value and 54 verified shipments. VIATRIS HEALTHCARE (PTY) LTD, holds a 0.7% market share in Tenofovir imports based in SOUTH AFRICA. The company sources from 1 verified supplier across 11 formulations shipped to 1 country.
VIATRIS HEALTHCARE (PTY) LTD, — Tenofovir Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Tenofovir to VIATRIS HEALTHCARE (PTY) LTD,?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $2.7M | 54 | 100.0% |
VIATRIS HEALTHCARE (PTY) LTD, sources Tenofovir from 1 verified Indian supplier based on 54 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does VIATRIS HEALTHCARE (PTY) LTD, Compare to Nearest Tenofovir Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | UNITED NATIONS DEVELOPMENT PROGRAMM | PAKISTAN | $1.1M | 22 | $50.0K |
| 16 | CHEMONICS INTERNATIONAL INC | HAITI | $800.0K | 16 | $50.0K |
| 9 | VIATRIS HEALTHCARE (PTY) LTD, ★ | SOUTH AFRICA | $650.0K | 13 | $50.0K |
| 3 | KENYA MEDICAL SUPPLIES | KENYA | $600.0K | 12 | $50.0K |
| 15 | ZYDUS FRANCE | FRANCE | $500.0K | 10 | $50.0K |
VIATRIS HEALTHCARE (PTY) LTD, ranks #9 among 1,436 Tenofovir importers from India. Average shipment value of $50.0K compared to the market average of $13.1K. The closest competitors by value are UNITED NATIONS DEVELOPMENT PROGRAMM and CHEMONICS INTERNATIONAL INC.
Where Does VIATRIS HEALTHCARE (PTY) LTD, Import Tenofovir To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $2.7M | 54 | 100.0% |
VIATRIS HEALTHCARE (PTY) LTD, imports Tenofovir to 1 country. The primary destination is SOUTH AFRICA receiving 100.0% of shipments worth $2.7M.
What Tenofovir Formulations Does VIATRIS HEALTHCARE (PTY) LTD, Import?
| Formulation | Value | Shipments |
|---|---|---|
| ACRIPTEGA TENOFOVIRDISOPROXILFUMARATE | $2.1M | 43 |
| TENEMINE TENOFOVIR DISOPROXIL FUMARATE300 MG+ EMTRICITABINE 200 MG TAB 28S 62922 PACKS X 28S = 1761816 NOS | $100.0K | 2 |
| EFLATEN TENOFOVIRDISOPROXILFUMARATE300M | $50.0K | 1 |
| TENEMINE 30'STENOFOVIRDISOPROXILFUMARAT | $50.0K | 1 |
| TENEMINE 28S TENOFOVIRDISOPROXILFUMARA | $50.0K | 1 |
| TENEMINE 28 S TENOFOVIR DISOPROXIL FUMARATE 300MG EMTRICITABINE 200MG TAB S PACKS 28 S BOTTLE 63210 P | $50.0K | 1 |
| TENEMINE 28 S TENOFOVIR DISOPROXIL FUMARATE 300 MG EMTRICITABINE 200MG TAB S PACKS 28 S BOTTLE 62494 | $50.0K | 1 |
| TENEMINE 28 S TENOFOVIR DISOPROXIL FUMARATE 300MG EMTRICITABINE 200MG TAB S PACKS 28 S BOTTLE 63344 P | $50.0K | 1 |
| TENEMINE 28 S TENOFOVIR DISOPROXIL FUMARATE 300MG EMTRICITABINE 200MG TAB S PACKS 28 S BOTTLE 62925 P | $50.0K | 1 |
| MYLONZATENOFOVIRDISOPROXILFUMARATE | $49.1K | 1 |
VIATRIS HEALTHCARE (PTY) LTD, imports 11 distinct Tenofovir formulations from India. The top formulation is ACRIPTEGA TENOFOVIRDISOPROXILFUMARATE with 43 shipments worth $2.1M.
Regulatory Requirements: Importing Tenofovir into South Africa
What VIATRIS HEALTHCARE (PTY) LTD, and other importers must comply with to import Tenofovir from India
Regulatory Authority
South African Health Products Regulatory Authority (SAHPRA)
Approval Process for Generic Tenofovir
Registration of generic medicines under SAHPRA guidelines based on CTD format. Bioequivalence required for generic applications.
Typical timeline: 24–48 months (significant backlog)
GMP Requirements
WHO GMP or PIC/S GMP compliance; SAHPRA may conduct overseas inspection
Import Licence & Documentation
Import permit from SAHPRA per Section 22A of the Medicines Act
Labeling & Packaging
English language labeling; SAHPRA scheduling status displayed
Note: SAHPRA has a known registration backlog. WHO Prequalification of the product or PIC/S certification of the site significantly assists the process.
Regulatory information is provided for general reference based on publicly available SAHPRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with SAHPRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Tenofovir from India and How Much Does VIATRIS HEALTHCARE (PTY) LTD, Import?
India exported $18.8M worth of Tenofovir through 7,518 shipments from 296 suppliers to 182 countries, serving 1,436 buyers globally. VIATRIS HEALTHCARE (PTY) LTD, imports $2.7M of this total, accounting for 0.7% of India's Tenofovir exports with 54 shipments from SOUTH AFRICA. This is verified from 54 customs shipment records covering 11 distinct formulations.
What Is the Average Order Value for VIATRIS HEALTHCARE (PTY) LTD,'s Tenofovir Imports?
VIATRIS HEALTHCARE (PTY) LTD,'s average Tenofovir order value is $49.4K per consignment, based on 54 shipments totaling $2.7M. VIATRIS HEALTHCARE (PTY) LTD, is based in SOUTH AFRICA and ranks #9 among all Tenofovir importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Tenofovir to VIATRIS HEALTHCARE (PTY) LTD,?
VIATRIS HEALTHCARE (PTY) LTD, sources Tenofovir from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($2.7M, 100.0%). This is based on 54 customs records.
How Does VIATRIS HEALTHCARE (PTY) LTD, Compare to Other Tenofovir Importers?
VIATRIS HEALTHCARE (PTY) LTD, ranks #9 among 1,436 Tenofovir importers from India with a 0.7% market share. The top 3 importers are MINISTRY OF HEALTH AND CHILD CARE ($4.5M), MINISTRY OF HEALTH ($3.5M), EMCURE PHARMACEUTICALS SA (PTY) LTD ($2.5M). VIATRIS HEALTHCARE (PTY) LTD, processed 54 shipments from SOUTH AFRICA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tenofovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tenofovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: VIATRIS HEALTHCARE (PTY) LTD, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as VIATRIS HEALTHCARE (PTY) LTD,'s capped import value divided by total capped export value for Tenofovir across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching VIATRIS HEALTHCARE (PTY) LTD, importing Tenofovir, covering 11 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 182+ countries, 1,436+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tenofovir Import Data for VIATRIS HEALTHCARE (PTY) LTD,
Access order-level details, pricing data, supplier connections, and competitive analysis for VIATRIS HEALTHCARE (PTY) LTD,'s Tenofovir imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
VIATRIS HEALTHCARE (PTY) LTD,
Company Profile
Multiple products · $0 total trade · Multiple categories
VIATRIS HEALTHCARE (PTY) LTD, × Tenofovir
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for VIATRIS HEALTHCARE (PTY) LTD,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tenofovir. For current order-level data, contact TransData Nexus.